Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of intrastriatal VGN-R09b in Parkinson's disease
CTR20242202Phase 2Active
- Sponsor
- T-MAXESTATE
- Start
- Sep 2024
- Modality
- AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of VGN-R09b in Parkinson's disease (PD), sponsored by T-MAXESTATE. Started Sep 2024; status: active.
02
Drugs
VGN-R09b
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20242202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242202.